Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors
In Brief: HHS Names Deputy HCFA Administrator; M.D. Anderson’s Error-Free Record Honored
FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs
Cancer Prevention; BCPT Enrollment Final At 13,000 After 5 Years
Receipt Dates Clarified For AIDS-Cancers PA
Letter; ASSIST Prevents Cancer, Should Remain in NCI Portfolio
Grants Funding; NCI Restores Paylines To Last Year’s Levels
AHCPR Funds Centers to Review Practice
Trending Stories
- “Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
In a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process - Prasad’s “deceit,” plus, ODAC’s tough decision against biomarker-based progression assessment (for now)
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Vinay Prasad’s CV inaccurately claims past membership on the President’s Cancer Panel
- DOJ alleges that Yale and UCLA discriminated based on race in medical school admissions
